Strides: Dr R Ananthanarayanan to depart as MD, Arun Kumar to take charge

Bengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has announced that Dr. R. Ananthanarayanan(Ananth) has decided to depart as Managing Director (MD) and Chief Executive Officer (CEO) of Strides, effective March 31, 2022, to pursue his personal interests outside the organization.

Consequently, Arun Kumar, Founder, will return to Strides in an executive role and assume the position of Executive Chairperson and Managing Director(MD) effective April 7, 2022.

Since January 2020, Ananth has been spearheading Strides and has been driving the strategic decisions around the future design of the organization. The Board of Directors of the Company (Board) accepted Ananth's resignation and thanked him for his leadership, commitment, enthusiasm, and motivation during his tenure at Strides in a challenging global operating environment.

Read also: Strides Pharma, Medicines Patent Pool ink pact to commercialize molnupiravir for global markets

Commenting on the updates, Arun Kumar remarked, "We thank Ananth for his leadership during his tenure at Strides in a tough global operating environment. Ananth has been closely working with the Board to recalibrate the growth and profitability of the Company and our priority is to continue building on those strategic and operational initiatives. The Company remains committed to enabling a fast turnaround of its business performance and delivering sustainable outcomes. "

Read also: Strides Pharma gets USFDA nod for colchicine tablets

Read also: Ms. Chandra Ganjoo to lead Trivitron Healthcare as Group CEO